𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European multicenter association study of affective disorders

✍ Scribed by Massat, Isabelle ;Souery, Daniel ;Del-Favero, Jurgen ;Van Gestel, Sofie ;Serretti, Alessandro ;Macciardi, Fabio ;Smeraldi, Enrico ;Kaneva, Radka ;Adolfsson, Rolf ;Nylander, Peter O. ;Blackwood, Douglas ;Muir, Walter ;Papadimitriou, George N. ;Dikeos, Dimitris ;Oru?, Lilijana ;Segman, Ronnen H. ;Ivezi?, Sladjana ;Aschauer, Harold ;Ackenheil, Manfred ;Fuchshuber, S. ;Dam, Henrik ;Jakovljevi?, Miro ;Peltonen, Leena ;Hilger, Christiane ;Hentges, Fran�ois ;Staner, Luc ;Milanova, Vihra ;Jazin, Elena ;Lerer, Bernard ;Van Broeckhoven, Christine ;Mendlewicz, Julien

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
237 KB
Volume
114
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Convincing evidence for a genetic component in the etiology of affective disorders (AD), including bipolar affective disorder (BPAD) and unipolar affective disorder (UPAD), is supported by traditional and molecular genetic studies. Most arguments lead to the complex inheritance hypothesis, suggesting that the mode of inheritance is probably not Mendelian but most likely oligogenic (or polygenic) and that the contribution of genes could be moderate or weak. The purpose of the present European multicenter study (13 centers) was to test the potential role in BPAD and UPAD of two candidate dopaminergic markers, DRD2 and DRD3, using a case‐control association design. The following samples were analyzed for DRD2: 358 BPAD/358 control (C) and 133 UPAD/ 133 C subjects, and for DRD3: 325 BPAD/ 325 C and 136 UPAD/136 C subjects. Patients and controls were individually matched for sex, age ( ± five years) and geographical origin. Evidence for significant association between BPAD and DRD2 emerged, with an over‐representation of genotype 5‐5 (P = 0.004) and allele 5 (P = 0.002) in BPAD cases compared to controls. No association was found for DRD2 in UPAD, and for DRD3 neither in BPAD or UPAD. Our results suggest that the DRD2 microsatellite may be in linkage disequilibrium with a nearby genetic variant involved in the susceptibility to BPAD. Our large European sample allowed for replicating of some previous reported positive findings obtained in other study populations. © 2002 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

No association of a functional polymorph
No association of a functional polymorphism in the dopamine D2 receptor promoter region with bipolar or unipolar affective disorders
✍ Furlong, Robert A.; Coleman, Tabytha A.; Ho, Luk; Rubinsztein, Judy S.; Walsh, C 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 14 KB 👁 2 views

The dopaminergic system, along with the serotonergic and noradrenergic systems, has been implicated in the etiology of mood disorders. An association study of a functional variant in the promoter region of the dopamine D2 receptor (DRD2) with bipolar affective disorder I or unipolar major affective

No evidence of association between dopam
No evidence of association between dopamine D3 receptor gene and bipolar affective disorder
✍ Piccardi, M. Paola; Severino, Giovanni; Bocchetta, Alberto; Palmas, M. Antoniett 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

A recent study reported a possible association between allele 1 of the dopamine D 3 receptor gene and bipolar affective disorder using the haplotype relative risk approach. In attempt to replicate these findings, we used similar family-based methods, such as the Haplotype-Based Haplotype Relative Ri

Further association study on dopamine D2
Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders
✍ Arinami, Tadao; Itokawa, Masanari; Aoki, Junichi; Shibuya, Haruo; Ookubo, Yoshir 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 1 views

The dopamine D2 receptor gene is a candidate gene for schizophrenia because the potency of certain neuroleptics correlates with their affinity for this receptor, Casecontrol studies in 291 schizophrenics, 78 patients with affective disorders, and 579 controls on an association of a molecular variant